Search

Displaying results 6881 - 6890 of 9313 in total
  1. Drug

    MLN3897

    go.drugbank.com/drugs/DB06505
    Experimental

    MLN3897, a novel CCR1 inhibitor, disrupts osteoclast formation and blocks the interaction between multiple myeloma cells and osteoclasts.

    Synonyms: (4S)-4-(4-CHLOROPHENYL)-1-((3E)-3-(9-(1-HYDROXY-1-METHYL-ETHYL)-5H-(1)BENZOXEPINO(3,4-B)PYRIDIN-11-YLIDENE)PROPYL)-3,3-DIMETHYL-PIPERIDIN-4-OL
  2. Drug

    Nesbuvir

    go.drugbank.com/drugs/DB07238
    Investigational

    Nesbuvir has been investigated for the treatment of Hepatitis C.

  3. Drug

    Emodin

    go.drugbank.com/drugs/DB07715
    Investigational

    Emodin has been investigated for the treatment of Polycystic Kidney.

  4. Drug

    Bapineuzumab

    go.drugbank.com/drugs/DB11715
    Investigational

    Bapineuzumab has been investigated for the treatment of Alzheimer's Disease.

  5. Drug

    Pefcalcitol

    go.drugbank.com/drugs/DB11786
    Investigational

    Pefcalcitol has been investigated for the basic science of Psoriasis.

  6. Drug

    Vamifeport

    go.drugbank.com/drugs/DB17692
    Investigational

    Vamifeport is being investigated for the treatment of beta-thalassemia.

  7. Drug

    Bi104

    go.drugbank.com/drugs/DB18743
    Experimental

    Bi104 is being investigated for the treatment of Angelman syndrome.

  8. Drug

    Doxifluridine

    go.drugbank.com/drugs/DB12947
    Investigational

    Doxifluridine has been investigated for the treatment of Stomach Cancer.

  9. Drug

    Saroglitazar

    go.drugbank.com/drugs/DB13115
    Investigational

    Saroglitazar has been investigated for the treatment of Fatty Liver.

  10. Drug

    Aminomethylbenzoic acid

    go.drugbank.com/drugs/DB13244
    Experimental

    Aminomethylbenzoic acid may be useful as an antifibrinolytic agent [A174994].